January 4, 2021
The Vineti Alliance Network — a preview of what’s next
For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One of the ways we’ve been able to do that is through our Alliance Network, launched earlier in the year to provide an enterprise-grade approach to the pre-integrated solutions that advanced therapy manufacturers need.
The Vineti Alliance Network continues to grow, with 15 publicly-announced ecosystem alliances and more on the way. And the network is growing not just in terms of the number of collaborations, but also their nature.
Over the course of the year, we’ve seen expanded demand not only for supply chain technology solutions that connect to our Personalized Therapy Management® (PTM) platform. We’re also seeing a growing need for packaged solutions that bring service providers into the loop. More certified consulting resources are needed across the advanced therapy ecosystem, and more quickly-deployed solutions are needed for the more than 1,070 clinical trials currently running in regenerative medicine.
With an eye on those industry needs, here’s a preview of how we’ll be expanding our Alliance Network in 2021:
- More pre-configured digital integrations with leading supply chain partners.
- Packaged professional services with key consulting firms and CROs (Contract Research Organizations).
- More professional training, including shared training with alliance partners for biopharmaceutical clients.
We’re working continuously to expand the Vineti Alliance Network with the following types of partners:
- Consulting and Systems Integration
- Contract Manufacturing
- Contract Research
- Patient Services
- Provider Sites
- Software Vendors
Even as the Vineti Alliance Network grows, our goals for these integrated solutions remain the same — faster time to market for advanced therapy manufacturers, lower project costs, and “gold standard” regulatory compliance. We’ll be sharing more detail on expansion plans for the network soon.
If you share this vision on behalf of advanced therapies and would like to join our Alliance Network, please contact us. We’d love to talk about working together on behalf of advanced therapies and the patients they serve.
Amy DuRoss is CEO and Co-founder of Vineti. You can learn more about Vineti’s Personalized Therapy Management® (PTM) platform and how our digital solution supports advanced therapy supply chains here.